INTERCEPT: a feasibility study of a digital intervention by nurse prescribers for secondary prevention of cardiovascular disease

Abstract Background Patients with coronary disease are commonly diagnosed, revascularised and discharged from hospital within 24-72 hours and only about one third access cardiac rehabilitation often with delays of weeks before joining such programmes. Purpose To bridge this care gap we developed the INTERCEPT digital model for secondary prevention. It comprises an I-App on a smart device, linked to wearables, and a Health Professional Portal overseen by a nurse prescriber in hospital to monitor and manage patients virtually. It was developed by co-design with patients, health professionals and a software company. The I-App encompasses lifestyle, risk factor control to targets and cardioprotective medications. Methods We conducted a feasibility study in the CCU/CTU at a University Hospital in patients with an acute coronary syndrome or elective revascularisation. The primary objective was to examine the feasibility of patient recruitment, engagement and usage from the I-App analytical data and acceptability of this form of preventive care among patients through qualitative interviews. Results 40 patients were recruited: mean age of 61.9 years (13% female); 56% STEMI/NSTEMI, 18% unstable angina, 26% elective PTCA/CABG. 25% were smoking, Mediterranean diet score 6.5 (SD 1.8), 87% BMI > 25 Kg/m2 and 68% low or moderate (IPAQ) physical activity. HADS: 27% anxiety >8 and 14% depression score >8. 58% had a BP